Signalling by TGF-b ligands through the Smad family of transcription factors is critical for developmental patterning and growth. Disruption of this pathway has been observed in various cancers. In vertebrates, members of the Ski/Sno protein family can act as negative regulators of TGF-b signalling, interfering with the Smad machinery to inhibit the transcriptional output of this pathway. In some contexts ski/sno genes function as tumour suppressors, but they were originally identified as oncogenes, whose expression is up-regulated in many tumours. These growth regulatory effects and the normal physiological functions of Ski/Sno proteins have been proposed to result from changes in TGF-b signalling. However, this model is controversial and may be over-simplified, because recent findings indicate that Ski/Sno proteins can affect other signalling pathways. To address this issue in an in vivo context, we have analyzed the function of the Drosophila Ski/Sno orthologue, SnoN. We found that SnoN inhibits growth when overexpressed, indicating a tumour suppressor role in flies. It can act in multiple tissues to selectively and cell autonomously antagonise signalling by TGF-b ligands from both the BMP and Activin sub-families. By contrast, analysis of a snoN mutant indicates that the gene does not play a global role in TGF-b-mediated functions, but specifically inhibits TGF-b-induced wing vein formation. We propose that SnoN normally functions redundantly with other TGF-b pathway antagonists to finely adjust signalling levels, but that it can behave as an extremely potent inhibitor of TGF-b signalling when highly expressed, highlighting the significance of its deregulation in cancer cells.
Introduction
The TGF-b signalling pathway is used reiteratively during development in both vertebrates and invertebrates to regulate patterning and growth (Massagué, 1998) . In humans, reduced TGF-b signalling is associated with several forms of cancers, although paradoxically increased signalling can promote growth and invasion of other tumours (Siegel and Massagué, 2003; Bachman and Park, 2005) . Analysis of orthologous components of the TGF-b signalling cascade has been instrumental in furthering our understanding of this pathway's complex functions. In the fruit fly Drosophila melanogaster, TGF-b signalling is stimulated by the binding of TGF-b ligands including Activin, Decapentaplegic (Dpp) , and Glass bottom boat (Gbb) to a set of serine/threonine kinase receptors (type I and II) on the plasma membrane (Parker et al., 2004 or Saxophone). The type I receptor then phosphorylates a receptor-associated Smad (R-Smad; Mad or dSmad2), which forms a complex with a cytoplasmic co-Smad (Medea). This Smad complex translocates into the nucleus where it binds promoters of TGF-b target genes to regulate transcription.
In Drosophila, Activin signalling is required for growth, cell proliferation and survival (Brummel et al., 1999) and Dpp/Gbb signalling is involved in both growth (Martín-Castellanos and Edgar, 2002; Rogulja and Irvine, 2005) , and embryonic and appendage patterning events such as the formation of wing veins (Raftery and Sutherland, 1999; O'Connor et al., 2006) . TGF-b signalling is negatively regulated through various mechanisms (Massagué et al., 2005; Shi and Massagué, 2003) , including at the level of transcriptional output through the activity of transcriptional repressors such as Brinker in Drosophila (Affolter et al., 2001) and Ski/Sno molecules in vertebrates (Luo, 2004) .
Ski/Sno proteins do not have any catalytic activity but function through protein-protein interactions (Luo, 2004; Reed et al., 2005) . Their best characterized mode of action is the transcriptional inhibition of TGF-b target genes. By binding to the MH2 (Mad Homology Domain 2) domain of R-Smads and/or the co-Smad Akiyoshi et al., 1999; Luo et al., 1999; Sun et al., 1999; Xu et al., 2000) , they can either disrupt the Smad complex in the cytoplasm and prevent proper assembly, or act in the nucleus in the Smad complex as classical co-repressors to prevent the binding of Smad co-activators such as p300/ CBP (Akiyoshi et al., 1999; Wu et al., 2002) . Ski/Sno family members can also recruit the chromatin modification machinery such as histone deacetylase and Sin3 at the promoters of Smad target genes to repress transcription Akiyoshi et al., 1999; Luo et al., 1999) . Thus, in cell culture and in Xenopus, transcriptional activation of TGF-b target genes is reduced upon Ski/Sno overexpression (Wang et al., 2000; Stroschein et al., 1999) .
Ski/Sno proteins regulate both growth and patterning. v-Ski, the founding family member, was isolated from the Sloan-Kettering retrovirus as a transforming protein of chicken embryo fibroblasts (Li et al., 1986) . Overexpression of c-Ski (cellular-Ski) or SnoN in chicken and mammalian cell culture leads to transformation and anchorage-independent growth (Colmenares and Stavnezer, 1989; Colmenares et al., 1991; Boyer et al., 1993) . The fact that various cancer cell lines and tumour tissue from patients also express high levels of Ski/Sno proteins is consistent with the proposed oncogenic role of these proteins (Nomura et al., 1989; Zhang et al., 2003; Buess et al., 2004) . SnoN mutant proteins that are unable to bind Smads fail to inhibit TGF-b-induced growth arrest of chicken embryonic fibroblasts (He et al., 2003) , suggesting that TGF-b repression is an important aspect of Ski/Sno oncogenic function.
TGF-b has both tumour-suppressing and oncogenic roles (Siegel and Massagué, 2003; Bachman and Park, 2005) , and several recent studies have shown that Ski/Sno proteins can also function as tumour suppressors. For instance, increased proliferation is observed in embryonic fibroblasts derived from ski +/À , ski À/À or snoN +/À mice, and ski +/À and snoN +/À mice also show an increased susceptibility to tumour formation (Shinagawa et al., 2000; Shinagawa et al., 2001) . A recent study confirmed the dual property of SnoN in tumorigenesis as mammalian SnoN displays a pro-tumorigenic activity at early stages of tumor growth and anti-tumorigenic activity at later stages (Zhu et al., 2007) . In addition, loss of Ski/Sno affects several known TGF-b-dependent patterning events such as dorsoventral patterning in zebrafish and craniofacial development in the mouse, but these defects have not been directly linked to increased TGF-b signalling (Berk et al., 1997; Colmenares et al., 2002; Cui et al., 2001) . Only in Caenorhabditis elegans has the Ski/Sno homologue, DAF-5, been genetically linked to the TGF-b pathway in vivo (da Graca et al., 2004) . Thus, it is still unclear what the in vivo role of Ski/Sno proteins is with regard to growth and patterning, and if all the overexpression and mutant phenotypes observed in higher organisms are related to modulation of TGF-b signalling, particularly since these molecules have more recently been proposed to affect several other signalling cascades (Liu et al., 2001; Dai et al., 2002; Chen et al., 2003; Zhu et al., 2007) .
Despite the identification and description of most components of the TGF-b pathway in Drosophila, the known orthologue of the Ski/Sno protein, SnoN, has not been studied in this model system. Here, we present its functional analysis. We first identified SnoN as a growth inhibitor in an overexpression screen for novel growth regulators. We demonstrate genetically and molecularly that SnoN overexpression strongly inhibits Dpp and Activin signalling in several developmental scenarios in vivo. Interestingly, its requirement during development appears to be much more restricted, playing a specific role in modulating the induction of wing vein formation by Dpp. Our data suggest that Drosophila SnoN normally fine-tunes the maintenance of specific TGF-b-regulated events, but can dominantly suppress TGF-b signalling in a much broader range of cellular scenarios when overexpressed as in tumour cells.
Results

SnoN overexpression inhibits growth and affects wing patterning
In the course of a UAS/GAL4-based overexpression screen for novel growth regulators in Drosophila, we identified SnoN as a growth inhibitor.
Two EP lines (Rørth, 1996) , EP(2)2510 and EP(2)2004, as well as a GS line (Toba et al., 1999) , GS18054, which are all located upstream of the snoN (CG7233) open reading frame (ORF), gave similar results when crossed to various GAL4 drivers. snoN EP(2)2004 , snoN EP(2)2510 , and snoN
GS18054
were first combined with the GMR-GAL4 driver, which promotes gene expression primarily in post-mitotic cells posterior to the morphogenetic furrow. This driver has been particularly useful in identifying genes with a role in cell growth control (e.g. see Goberdhan et al., 2005) . snoN EP/GS /GMR-GAL4 eyes were reduced in size and contained regularly arranged, but smaller ommatidia (Fig. 1B,B 0 and data not shown). Inspection of the arrangement of cells in individual ommatidia in snoN EP(2)2510 /GMR-GAL4 pupal eyes revealed that they were patterned normally (Suppl. Fig.1 ), indicating that snoN EP(2)2510 -driven overexpression specifically affects cell growth in the differentiating eye.
To investigate whether the growth inhibition phenotype is a general feature of snoN EP/GS -driven overexpression, we used the MS1096-GAL4 wing driver, which drives gene expression predominantly on the dorsal wing surface (Capdevila and Guerrero, 1994) . This driver has been used to study growth in the wing (e.g. see Radimerski et al., 2002 and Raisin et al., 2003) . Wings of MS1096-GAL4; sno-N EP/GS flies were smaller than normal and up-turned, consistent with a role in inhibiting tissue growth ( Fig. 1E and data not shown). Small wing phenotypes were also observed with other wing drivers such as apterous-, scalloped-, and 32B-GAL4 ( Fig. 1H and data not shown). Ubiquitous snoN EP/GS overexpression in developing flies typically produced a lethal phenotype during larval and pupal development (data not shown).
To confirm that all the phenotypes produced with snoN EP(2)2004 , snoN EP(2)2510 , and snoN GS18054 are due to SnoN misexpression, we generated UAS-snoN transgenic flies. As expected, these produced similar phenotypes to the snoN EP/GS lines, although varying in severity with different GAL4 drivers (Fig. 1C,C 0 ,F,I and data not shown). While SnoN overexpression specifically affects growth in the differentiating eye, we found that both growth and patterning are affected in wings. With various wing drivers, we consistently observed a loss of vein tissue. For instance, distal truncations of longitudinal veins (LV) and loss of crossveins were observed in snoN GS18054 ; 32B-GAL4 and UAS-snoN; 32B-GAL4 wings (Fig. 1H,I ). Overexpressed Drosophila SnoN, therefore, inhibits cell and tissue growth, consistent with SnoN having putative tumour suppressor activity, and affects patterning events that are known to require TGF-b activity such as wing vein formation.
The genomic organization of snoN in Drosophila and comparative analysis of the Drosophila SnoN protein sequence
The locations of the transposable elements tested above were verified by PCR or inverse PCR. Importantly the 297{}323 retrotransposon present in the FlyBase genomic annotation and Oregon R wild-type flies is absent from all the insertion lines we analysed and from wild-type Canton S flies. Thus, the EP(2)2004 and EP(2)2510 elements are located only about 1 kb upstream of the snoN ORF, while GS18054 is located about 0.7 kb upstream ( Fig. 2A) . The annotated Drosophila SnoN protein is 338 amino acids long with a molecular weight predicted to be about 38 kDa. Blast homology search and protein-protein alignment showed that fly SnoN is orthologous to Ski/Sno proteins (see alignment in Suppl. Fig. 2 and Mizuhara et al., 2005) . It contains the Ski/Sno family domain, characterized by conserved CLPQ residues ( Fig. 2B and Suppl. Fig. 2) , which is known to be essential for the transforming and differentiation activities of Ski/Sno proteins (Zheng et al., 1997) . It also includes the conserved SAND domain, which, in mammals, is required to mediate binding of Ski to Smad4 ( Fig. 2B ; Wu et al., 2002) . However, it lacks the C-terminal region, present in chicken and human Ski/ SnoN (but not mouse) that is involved in dimerization of Ski/Sno proteins ( Fig. 2B ; Liu et al., 2001 ). Thus, Drosophila SnoN displays most, but not all, of the conserved domains present in vertebrate Ski/Sno proteins.
Drosophila SnoN overexpression inhibits TGF-b signalling in vivo
Overexpression of Dpp or Activin pathway components in the developing eye and wing can lead to increased growth and proliferation (Brummel et al., 1999; Martín-Castellanos and Edgar, 2002; Rogulja and Irvine, 2005 ; Fig. 3 ). In the wing, reduced Dpp or Gbb activity produces distal truncations of longitudinal veins (de Celis, 1997; Ray and Wharton, 2001 ). Because SnoN is a known negative regulator of TGF-b signalling in other systems (Luo, 2004) , we hypothesized that the effects of SnoN overexpression could be due to the inhibition of TGF-b signalling.
To test this, we overexpressed components of the Dpp or Activin pathways with GMR-GAL4, in the absence or presence of overexpressed SnoN (Fig. 3) . Overexpression of an activated form of the type I Dpp receptor Thickveins (Tkv QD ; Nellen et al., 1996) produced enlarged eyes containing larger ommatidia than controls (Fig. 3B) . Some patterning defects were also present. Co-overexpression of SnoN was able to completely suppress both the overgrowth and patterning phenotypes (Fig. 3F ). Upon overexpression of an activated form of the type I Activin receptor Baboon (Babo*; Brummel et al., 1999) , even larger eyes and ommatidia were observed with much more severe patterning defects (Fig. 3C ). This phenotype was also strongly, but not completely, suppressed by SnoN overexpression (Fig. 3G) .
To determine whether the growth-suppressing effects of SnoN overexpression in the differentiating eye are TGF-b-specific, we also tested whether SnoN could suppress the overgrowth phenotype generated upon insulin receptor (InR) signalling activation. Overexpression of Akt1, a kinase and positive regulatory component of the InR pathway, led to significantly larger eyes with larger ommatidia ( Fig. 3D ; Goberdhan et al., 2005) . Co-overexpression of SnoN was unable to suppress this overgrowth phenotype (Fig. 3H) . Thus, SnoN overexpression appears to suppress growth in the differentiating eye by specifically inhibiting TGF-b signalling.
To investigate whether the suppression of TGF-b overexpression phenotypes by overexpressed SnoN is tissuespecific or reflects a more general function, we looked for genetic interactions in the wing. We tested if SnoN overexpression could suppress an Activin-overexpression phenotype. When Babo* was overexpressed in the posterior compartment of the wing with engrailed-GAL4 (en-GAL4), ectopic wing vein material was observed and the compartment became enlarged relative to wild-type wings ( Fig. 3K) , presumably reflecting the growth-stimulating properties of the Activin pathway in this tissue (Brummel et al., 1999) . The wing vein and overgrowth phenotypes were significantly suppressed by co-overexpression of SnoN in the same compartment (Fig. 3L) .
In vertebrates, Ski/Sno molecules modulate TGF-b transcriptional output through interaction with Smads (Luo, 2004) . To investigate whether fly SnoN also affects TGF-b-dependent gene transcription, we looked at the expression of Optomotor-blind (Omb; using an omb-lacZ reporter construct), a known transcriptional target of Dpp in the wing (Grimm and Pflugfelder, 1996) . In wildtype wings, Omb expression is centered along the anterior-posterior compartment boundary, where Dpp is produced, and extends into mediolateral regions of the disc (Fig. 4A ). All cells in SnoN-overexpressing clones, when located in the Omb domain, showed a cell autonomous reduction/absence of Omb expression ( Fig. 4D-F ; n = 50 clones in 36 discs). Thus, Drosophila SnoN dominantly suppresses both Activin-(Babo-) and Dpp-dependent phenotypes in the eye and wing, and cell autonomously inhibits the transcription of a Dpp target gene in the wing, consistent with its proposed role as an inhibitor of Smad function in vertebrates.
snoN mutant flies are viable, show no growth defects, but display a subtle wing vein patterning phenotype
To assess if endogenous Drosophila SnoN normally regulates growth and patterning and to further understand its link to TGF-b and other signalling cascades, we generated a snoN mutant. An EMS screen looking for revertants of the MS1096-GAL4; snoN GS18054 phenotype resulted in the identification of one complete revertant (see Section 4; Fig. 5C and I), with a C to T transition at nucleotide number 517 in the snoN ORF. This results in a premature stop codon (Suppl. Fig. 2 ). As a result, the predicted mutant SnoN protein is 172 amino acids long and lacks parts of the molecule that are critical for the normal function of vertebrate Ski/Sno proteins, including about one third of the conserved Ski/Sno family domain as well as the entire SAND domain (Fig. 2B) . Thus, snoN GS-C517T is predicted to be a strong loss-offunction mutation. snoN GS-C517T homozygous flies are viable and display a near normal morphology, but they show reduced fertility in females (data not shown). Detailed analysis did not reveal any significant growth phenotype in heterozygous or homozygous flies, either in whole animals or in individual structures like the wing and eye ( Fig. 5B and F ; data not shown), and with the exception of the wing, no patterning defects were observed. This suggests that despite SnoN's potent inhibitory effects on TGF-b signalling when overexpressed, it does not play an essential role in most aspects of TGF-b-regulated development. Overexpression of UAS-tkv QD (B) or UAS-babo* (C) with GMR-GAL4 results in large eyes with patterning defects (arrowhead in B,C). Coovexpression of SnoN using snoN EP(2)2510 suppresses both the growth and patterning phenotypes (F,G). Overexpression of UAS-Akt1 also results in larger eyes (D) but co-overexpression of SnoN is unable to significantly reduce the overgrowth phenotype (H). *p < 0.001 when compared to a, **p < 0.005 when compared to (A), ***p < 0.001 when compared to (B), ****p < 0.001 when compared to (C), *****p > 0.5 when compared to (D). Overexpression of SnoN (J) in the posterior compartment of the wing, using en-GAL4, results in decreased compartment size compared to control (I). In contrast, overexpression of UAS-babo* (K) results in a larger posterior compartment compared to control (I). Co-overexpression of SnoN (L) can partially suppress the overgrowth phenotype generated by Babo* overexpression (K; p < 0.001). P/A: posterior to anterior compartment size ratio. Note that overexpression of Babo* leads to some ectopic vein tissue around L4 and the PCV (K). This phenotype is also largely suppressed by SnoN co-overexpression (L). GS-C517T mutants are viable, display no growth defects and show an ectopic wing vein phenotype. snoN GS-C517T homozygous mutant eyes (B) are normally patterned and are not smaller or larger than wild-type eyes ((A) relative sizes in bottom right corner of each panel). Overexpression of snoN GS-C517T with GMR-GAL4 (C) also does not affect growth, but overexpression of the original snoN GS18054 insert with GMR-GAL4 (D) does. The wings of homozygous snoN GS-C517T flies (F) show ectopic wing vein tissue around the PCV and next to L5 (arrowheads) when compared to control homozygous snoN GS18054 flies (E). Growth of the wing is not affected. Close-up view of the PCV/L5 region shows that the ectopic wing veins (H) are fully differentiated. Adult flies overexpressing wild-type ((J) arrowhead marks upturned wing) or mutant SnoN (I) using apterous-GAL4. Note the unusual shape of the notum in ap-GAL4/snoN GS18054 flies (arrow) caused by the failure of dorsal thoracic closure. In panels (E,F) anterior is at the top. *p < 0.001 when compared to control.
The only visible defect in snoN GS-C517T homozygotes was the presence of ectopic wing vein tissue in over 90% of flies (Table 1) , occasionally around L2, but more consistently in the vicinity of the posterior crossvein (PCV) and L5 ( Fig. 5F and H) . Homozygous snoN GS18054 founder flies did not present this phenotype ( Fig. 5E and G) . Ectopic veins located posterior to L5 had a dorsal corrugation (bristles protruding dorsally, 8/8 cases, Fig. 5H ), which is characteristic of distal L5 (de Celis, 2003) . In contrast, ectopic veins protruding from the PCV and anterior to L5 mostly had a ventral identity (5/6 cases; Fig. 5H ). Interestingly, we found that approximately 20% of snoN heterozygous flies also displayed the ectopic vein phenotype, although the precise frequency depends on genetic background (Table 1 ; data not shown).
The snoN GS-C517T mutation does not affect snoN transcript levels as judged by in situ hybridization in imaginal discs (data not shown). Hence, the SnoN GS-C517T mutant protein is probably translated and could interfere with wild-type SnoN. To test this, we overexpressed SnoN GS-C517T with strong ubiquitous drivers such as actinand tubulin-GAL4. The progeny were viable (in comparison, snoN GS18054 in combination with these drivers is lethal), and appeared wild-type in morphology, except for the presence of multiple ectopic wing veins in the L5 region (Table 1 ; strength of phenotype +++). These results suggest that snoN GS-C517T acts as a dominant negative allele, in addition to lacking normal SnoN function. Even when expressed at high levels throughout the developing animal, this allele only disrupts wing vein development around L5 (and more rarely L2).
To confirm that the ectopic wing vein phenotype observed in snoN GS-C517T homozygous flies is actually due to the snoN mutation, we attempted to rescue the phenotype of mutant flies with our wild-type UAS-snoN transgene. However, overexpression of the wild-type protein alone with most GAL4 drivers induces a strong phenotype and even with the weak ubiquitous driver armadillo-GAL4, only a few defective escaper flies survive. To circumvent this problem, we overexpressed wild-type SnoN specifically in the interveins using the bs1348-GAL4 driver (Huppert et al., 1997) . This fully rescued the majority of flies with only 17% still displaying an ectopic wing vein phenotype (vs 94% in mutants; Table 1 ). Thus, although as with any dominant negative alleles, we cannot easily exclude the possibility that snoN GS-C517T can also indirectly affect non-SnoN-dependent functions, we conclude that the snoN GS-C517T mutant phenotype is primarily explained by reduction of normal SnoN function. snoN GS-C517T appears to be a strong loss-of-function allele, since all overexpression phenotypes seen with the wild-type gene are completely reverted (Fig. 5 and data not shown). However, when we generated flies transheterozygous for snoN GS-C517T and a large deficiency (203 kb) for the snoN gene Df(2L)ED12527, we found that these animals showed a significantly reduced number of ectopic wing veins compared to homozygous snoN GS-C517T flies (Table 1) . One explanation for this result is that the dominant negative snoN GS-C517T allele not only interferes with SnoN-dependent inhibition of wing vein formation, but also with other molecules involved in this process that would not be affected in the complete absence of snoN. However, the deficiency chromosome also suppressed the frequency of ectopic wing veins in flies overexpressing the mutant protein under tub-GAL4 control (Table 1) , thus indicating that there may be an additional mutation on the deficiency chromosome that reduces TGF-b signalling and therefore, suppresses the snoN
GS-C517T
-induced wing vein phenotype. Table 1 The (de Celis, 2003) . Dpp/Gbb activity is known to influence two stages of vein formation. First, it is required to establish the position of the wing vein primordia in late third instar larvae (Bangi and Wharton, 2006) . Second, it directs the vein differentiation programme in pupae (de Celis, 1997; Sotillos and de Celis, 2005; Ralston and Blair, 2005) . To identify when the snoN GS-C517T mutant phenotype is first established, we monitored vein formation during these two stages.
At the end of third instar, the vein primordia express Delta (Dl; Fig. 6A ; Biehs et al., 1998 ) and the L5 primordium is established at the posterior edge of the Omb domain ( Fig. 6B ; Cook et al., 2004) . The expression of Omb and Dl in snoN GS-C517T , tub-GAL4 wing discs ( Fig. 6D-F ; n = 17 discs) appeared normal compared to control discs ( Fig. 6A-C ; n = 7), although our assay may not be sensitive enough to detect changes involved in the weak ectopic wing vein phenotype seen in snoN mutant adults.
During pupation, the prospective wing veins (proveins) express phosphorylated Mad (P-Mad; Conley et al., 2000) . Ectopic P-Mad-expressing tissue was readily detected in snoN GS-C517T , tub-GAL4 pupal wings in a broad domain around distal L5 ( Fig. 6H ; 24 h APF). Presumably, this ectopic P-Mad is refined at later stages, since we observe discrete additional veins in adults (Fig. 5) . SnoN therefore appears to be involved in restricting vein differentiation to provein regions during pupation. To test whether SnoN overexpression at pupal stages was sufficient to suppress vein formation, we overexpressed wild-type SnoN in the proveins using a GAL4 driver that is pupal stage-specific (shv 3KPN -GAL4; Sotillos and de Celis, 2005) . As expected, this resulted in the loss of veins in adult wings (Fig. 6J) .
If SnoN normally functions in pupal discs to block wing vein formation, it is expected to be expressed in cells that do not form veins (interveins). We therefore, performed in situ hybridization for snoN mRNA. We first tested our snoN probe in young embryos and found that snoN was either not expressed or expressed at very low levels at early stages ( Fig. 7A and B) . snoN EP(2)2510 , en-GAL4 embryos showed strong snoN expression in a pattern consistent with wild-type en expression at this stage, showing that the probe was working ( Fig. 7C ; Kornberg et al., 1985) . In larval imaginal discs, snoN is broadly expressed (data not shown). In situ staining of pupal wing discs revealed that snoN mRNA is expressed primarily in interveins, especially in cells close to the proveins (arrowhead in Fig. 7D) . A P element enhancer trap line, l(2)SH1402, located about 0.7 kb upstream of snoN ( Fig. 2A ; Oh et al., 2003) , recapitulated endogenous snoN expression. Indeed, double ; tub-GAL4 discs (D-F) compared to control (A-C). (G,H) Immunostaining for P-Mad in pupal wing discs at 24 h APF. The position of the longitudinal proveins is indicated and the PCV is marked between the two white lines (also arrow in G). Ectopic P-Mad staining is visible around the L5 provein in snoN ; tub-GAL4 discs (H, arrow). Adult wings from flies overexpressing SnoN GS-C517T (I) or wild-type SnoN (J) with shv-GAL4 (pupal provein driver). L4, L5 and PCV tissues are lost upon wild-type SnoN overexpression (J, arrowheads). In panels (A-F), anterior is to the left. Scale bar, 50 lm.
staining for b-galactosidase and P-Mad (Fig. 7E-G) revealed a complementary staining pattern with strongest b-galactosidase expression directly adjacent to the PMad-expressing proveins (Fig. 7G) . Combined with our genetic analysis, these results suggest that SnoN acts in the pupal wing interveins to inhibit vein differentiation, although we cannot exclude the possibility that SnoN is involved in earlier vein patterning events.
SnoN inhibits Dpp activity to prevent vein differentiation
If the ectopic wing vein phenotype observed in snoN GS-C517T homozygous mutants is Dpp-dependent, then reduced levels of Dpp might be expected to lower the frequency or severity of the snoN GS-C517T mutant phenotype.
We tested two classes of dpp alleles with snoN GS-C517T . dpp d5 and dpp d6 are two dpp alleles that belong to the class of dpp disk alleles, which affect larval imaginal disc development (St Johnston et al., 1990) . A highly significant reduction in the number of flies showing ectopic wing veins was found in homozygous snoN GS-C517T mutant flies carrying one copy of either the dpp d5 or dpp d6 allele (Table 2) . A significant suppression was also obtained in snoN GS-C517T , tub-GAL4 flies, but it was weaker, probably because the severity of the ectopic wing vein phenotype is stronger in these flies (see Table 1 ). dpp S11 belongs to the class of dpp shortvein alleles (St Johnston et al., 1990) , which specifically affect Dpp activity during pupation (de Celis, 1997; Sotillos and de Celis, 2006) . A strong and significant reduction in the number of flies showing ectopic wing veins was observed in snoN GS-C517T tub-GAL4 animals heterozygous for dpp S11 (Table 2 ). Our data, therefore, show that the snoN GS-C517T phenotype is dependent on Dpp activity. The fact that both dpp disk and dpp shortvein alleles genetically interact with snoN GS-C517T indicates that SnoN may actually play a role not only in the pupal stage of vein formation but also during larval development.
Discussion
This paper describes a molecular genetic analysis of the single Ski/Sno family gene in Drosophila. In mammals, members of this family can act as oncogenes and tumour suppressors. We first identified fly SnoN as a growth inhibitor when overexpressed in wing and eye tissues. Our subsequent genetic analysis revealed that SnoN strongly suppresses Dpp-and Activin-dependent phenotypes, but that surprisingly loss of snoN function has very limited effects. 
The primary function of Drosophila SnoN is to antagonise Dpp and Activin signalling
SnoN overexpression produced a range of different patterning and growth phenotypes in the eye, wing and other tissues. The patterning defects that we observed are consistent with reduced TGF-b signalling, e.g. loss of wing veins with wing GAL4 drivers and failure of thorax closure when expressed in presumptive thoracic body wall epithelium (Figs. 1, 5J ; O'Connor et al., 2006; Martín-Blanco et al., 2000) . Dpp and Activin signalling have also been implicated in driving growth in the wing (Brummel et al., 1999; Martín-Castellanos and Edgar, 2002; Rogulja and Irvine, 2005) and so the growth inhibitory activity of SnoN in this tissue also fits with its proposed antagonistic function. Growth regulation by TGF-b signalling in the eye has been less extensively studied, but we were able to show that increasing either Dpp or Activin signalling primarily in differentiating cells promotes overgrowth and this is strongly suppressed by co-overexpression of SnoN (Fig. 3) . When SnoN is expressed by itself in the differentiating eye, its growth inhibitory effects appear to be entirely due to reduced cell growth and cell size ( Fig. 1 and Suppl. Fig. 1 ). Even though the disorganized patterning seen in eyes with excess TGF-b signalling (Fig. 3 ) may result from changes in cell number as well as cell size, these effects were also potently suppressed by SnoN.
It should be noted that Activin signalling was less efficiently suppressed by SnoN compared to Dpp signalling in both the eye and wing. Although our data support a role for SnoN in inhibiting Activin functions, we cannot exclude the possibility that there is cross-talk between the two TGF-b pathways, particularly in these overexpression assays, and that we are observing suppression of Activin's effects on the Dpp target Smad Mad. Resolution of this issue will require the identification of a specific Activin target gene in the wing or eye, as we have used for the Dpp pathway.
Overgrowth phenotypes are also observed upon overexpression of components of the InR signalling pathway (Goberdhan and Wilson, 2003) . Interestingly, we found that SnoN overexpression was unable to suppress the overgrowth generated by Akt1 overexpression, indicating that SnoN specifically acts downstream of TGF-b signalling. In fact, overexpressed Akt1 suppressed the growth inhibitory effects of SnoN. This is consistent with previous observations by Martín-Castellanos and Edgar (2002) who found that the effects of Tkv overexpression on growth are at least partly mediated by components of the InR signalling cascade.
By studying the regulation of an established Dpp target gene, omb, in the wing disc through clonal analysis, we found that SnoN inhibits Dpp signalling cell autonomously. Not only does this support our hypothesis that SnoN directly modulates TGF-b signalling in flies, but the cell autonomous behaviour of this molecule is consistent with its proposed role as a transcriptional modulator.
In vertebrates, Ski/Sno proteins have been implicated in the regulation of several different signalling cascades, including those involving Hedgehog and Wnt family proteins (Dai et al., 2002; Chen et al., 2003) , but the relevance of these interactions in vivo has remained unclear. Our overexpression data cannot exclude a role for SnoN in these other signalling pathways, but they do suggest a primary function in TGF-b signalling, a conclusion further supported by our mutant analysis (see below). Although the SnoN-TGF-b link has been suggested previously in vertebrate systems, primarily through overexpression approaches in cell culture, our analysis in Drosophila confirms the importance of this process in vivo. In addition, our results are also consistent with the idea that SnoN's effects on growth in whole animals may all be mediated through changes in TGF-b signalling, which in Drosophila primarily plays a growth-promoting role. Hence in flies, SnoN acts as a tumour suppressor, but just as in vertebrates, its effects on growth are most clearly observed when overexpressed.
Analysis of the snoN GS-C517T allele indicates that SnoN plays a highly restricted role in regulating TGF-b signalling during Drosophila development
We were surprised to find that flies homozygous for the snoN GS-C517T mutant allele develop with only minor patterning defects (ectopic wing veins). This suggests that SnoN has a highly restricted role in development. Since in situ analysis indicates that snoN is expressed quite broadly in imaginal discs (data not shown and Fig. 7) , this restricted role cannot be explained merely by localized gene expression.
We believe that snoN GS-C517T is likely to represent a strong loss-of-function allele for three reasons. First, it is predicted to produce a protein that lacks the entire evolutionarily conserved SAND domain, which interacts with Smad4 (co-Smad), and about one third of the Ski/Sno family domain, so it should not be able to antagonize the TGF-b signalling pathway. It also lacks regions required in mammalian Ski for binding to Gli3 (Hedgehog pathway; Dai et al., 2002) and FHL2 (Wnt pathway; Chen et al., 2003) . Thus, even if fly SnoN could interact with these signalling cascades, it is predicted that the mutant protein would not. Second, overexpression phenotypes observed with the snoN GS18054 insertion are all completely reverted by the mutation, indicating that the allele has lost its biological activity. Third, ubiquitous overexpression of the putative dominant negative snoN GS-C517T allele precisely phenocopies the homozygous mutant phenotype (see below for further discussion). Thus, our results suggest that Drosophila SnoN has no essential role in the majority of TGF-b-dependent events, despite its potent activity as a TGF-b signalling antagonist in flies and vertebrates. The developmental functions of snoN in mammalian development are not yet clear. Indeed, loss of SnoN function was shown to be embryonic lethal by Shinagawa et al. (2000) , but another group reported that two different snoN mouse mutants are viable and only show T-cell activation defects (Pearson-White and McDuffie, 2003) .
Several lines of evidence confirm that the ectopic wing vein phenotype observed in snoN GS-C517T homozygous flies results from inhibition of a SnoN-dependent function. First and most importantly, expression of wild-type SnoN with bs1348-GAL4 largely suppresses the snoN GS-C517T ectopic wing vein phenotype. In addition, the similarity between the mutant phenotype and the defects observed in situations where TGF-b activity is up-regulated, as well as the genetic interaction data with dpp alleles (Table 2) are fully consistent with the ectopic wing vein phenotype resulting from loss of a TGF-b signalling antagonist, such as SnoN.
The snoN GS-C517T allele also acts in a dominant negative fashion. Indeed, it specifically suppresses the normal function of SnoN (wing vein development inhibition), since strong constitutive overexpression of snoN GS-C517T accurately phenocopies the homozygous mutant phenotype. Moreover, in snoN GS-C517T , tub-GAL4 discs, we observed ectopic P-Mad expression specifically in the region around L5, where the adult phenotype is observed. This last result might appear to contradict models for vertebrate Ski/Sno function, in which these molecules act downstream of Smad activation. However, the pattern of P-Mad expression outside the longitudinal proveins is thought to evolve in a complex process involving long-range signalling and feedback regulation (Ralston and Blair, 2005; O'Connor et al., 2006) . Thus, increased Dpp transcriptional output in a snoN mutant could subsequently lead to increased P-Mad expression.
Could the snoN
GS-C517T allele disrupt only some SnoN-dependent functions?
While this paper was under review, an independent study of Drosophila SnoN was published by Takaesu et al. (2006) . They used the l(2)SH1402 chromosome that we have employed, and concluded that the recessive pupal lethal mutation on this chromosome is caused by a defect in snoN. The simplest explanation of our conflicting data is that despite the arguments given above, our snoN GS-C517T allele is hypomorphic.
In their paper, Takaesu et al. (2006) carried out an extensive molecular analysis of the snoN locus and identified multiple alternative transcripts, encoding four distinct protein isoforms: SnoI, SnoA, SnoN, and SnoN2. The CG7233 gene product (that we and Flybase call SnoN) corresponds to the SnoI isoform that they describe. Importantly, all the Sno protein isoforms share the same N-terminal region, including the Ski/Sno family domain and the SAND domain. Hence, the nonsense mutation we identified in our snoN GS-C517T flies should prevent the synthesis of functional protein for all four isoforms, assuming there is no readthrough of the nonsense mutation. In fact, many of the transcripts described by Takaesu and colleagues include sequences from the 297{}323 retrotransposon that is absent in many Drosophila strains, including wild-type Canton S, suggesting that other 5 0 promoters and splicing events must be used in these strains if the full complement of isoforms is to be made. All overexpression experiments described by these authors, which led to similar conclusions to our own, were performed with the same isoform as our study. Takaesu et al. (2006) suggest that the lethal mutation in the l(2)SH1402 chromosome is caused by loss of the 297{}323 retrotransposon affecting snoN expression, but as mentioned above, we have found this transposon to be absent even in wild-type flies. Thus, another as yet unidentified mutation must be responsible for the lethality. Surprisingly, we found that l(2)SH1402 complements the snoN deficiency chromosome used in our study. We have confirmed the boundaries of this deficiency and also specifically shown the absence of the 5 0 end of the snoN gene in the deficiency by PCR (see Section 4; data not shown). l(2)SH1402 also complements our snoN GS-C517T mutant, because l(2)SH1402/snoN GS-C517T animals are viable and display an ectopic wing vein phenotype at a frequency similar to snoN GS-C517T heterozygous flies (data not shown). These results suggest that the lethality observed in l(2)SH1402 flies is not entirely due to a disruption of SnoN's function, despite the fact that constitutive overexpression of snoN is reported to rescue the lethal phenotype. In light of these observations, we therefore believe that the snoN GS-C517T allele has retained little if any normal function and that the homozygous snoN GS-C517T phenotype, therefore, reflects the fact that this gene is not essential for viability in vivo.
3.4. SnoN may act redundantly with other Dpp inhibitors to fine-tune the output of Dpp signalling in the wing One inconsistency in our data is that ectopic wing vein frequency is reduced in snoN GS-C517T /Df(2L)ED12527 flies relative to homozygous snoN GS-C517T animals, suggesting that the effects of snoN GS-C517T are more severe than a complete loss-of-function allele. We have provided evidence that there may be another mutation in the deficiency region that represses TGF-b signalling, since this chromosome also partially suppresses the dominant negative effects of overexpressed SnoN GS-C517T (see Table 1 ). However, we cannot eliminate the possibility that part of the snoN GS-C517T homozygous mutant phenotype is caused by a dominant effect on other regulators of the TGF-b signalling cascade and this could explain the fact that overexpressed SnoN does not fully rescue this phenotype.
In this regard, it is already known that, in the process of pupal wing vein formation, at least three antagonists of Dpp signalling activity, Short-gastrulation (Sog), Brinker, and Daughter-against-Decapentaplegic, are able to block wing vein development upon overexpression (Yu et al., 1996; Sotillos and de Celis, 2005) . The intervein expression pattern of SnoN in pupal wings is similar to the expression of Sog (Yu et al., 1996) , an extracellular molecule that inhibits Dpp ligand binding, and Brinker (Sotillos and de Celis, 2005), which acts as a transcriptional repressor of Dpp target genes. Analysis of sog mutant clones in the wing suggests that Sog is required to limit longitudinal vein formation to the provein regions (Yu et al., 1996) . The wings of brinker mutant escapers display ectopic wing vein tissue (Lammel et al., 2000) , as do brinker mutant clones (Cook et al., 2004) . If the dominant negative SnoN GS-C517T protein can still complex to some of the molecules involved in Dpp signalling without inhibiting them, this might partially block the ability of these alternative antagonists to compensate for loss of normal SnoN function and therefore, produce a phenotype more severe than a snoN null allele.
In conclusion, we propose a model in which Drosophila SnoN normally plays a highly restricted role in TGF-b-dependent events. During development, the sensitivity of TGF-b signalling to SnoN levels may be important in providing a responsive mechanism to fine-tune and balance fluctuations in signalling. One prediction of this model is that snoN mutant phenotypes would be highly sensitive to the genetic background and to levels of TGF-b signalling, both of which we observed. The use of multiple potent, but partially redundant, inhibitors to control a fundamental signalling cascade is a powerful mechanism for maintaining stable levels of signalling activity. However, for snoN, such a mechanism carries the inherent risk that it can cause severe defects if its expression is altered, as is frequently observed in tumours.
Experimental procedures
Fly stocks
When not otherwise specified, stocks were obtained from the Bloomington Drosophila stock centre. snoN EP(2)2510 /CyO and snoN
/CyO (Rørth, 1996) stocks were originally obtained directly from Exelixis. The snoN GS18054 stock (Toba et al., 1999) was obtained from Toshiro Aigaki and is described in the Drosophila Gene Search Project website (http:// gsdb.biol.metro-u.ac.jp/~dclust/). The l(2)SH1402/Cyo stock (Oh et al., 2003 ; Szeged stock centre) is a PlacW insertion in the snoN 5 0 UTR and was used as a b-galactosidase snoN reporter line. Published insertion sites for these elements were confirmed by PCR or sequencing of inverse PCR products from insertion line genomic DNA. Both EP lines and the GS line are viable as homozygotes. The Df(2L)ED12527 deficiency line was obtained from the DrosDel collection at Szeged (http://www. drosdel.org.uk/#). Df(2L)ED12527 was first checked genetically for non-complementation with microtubule star (mts) alleles, since the mts gene should be absent from this chromosome. Additionally, the limits of the Df(2L)ED12527 deletion were verified by PCR and finally, the absence of the 5 0 region of the snoN gene was verified by PCR of genomic DNA from snoN GS-C517T /Df(2L)ED12527 and l(2)SH1402/Df(2L)ED12527 adults, using multiple combinations of primers flanking each insertion. The yw, omb-lacZ, hs flp 122 ; AyGAL4 UAS-eGFP stock was a gift from Daimark Bennett. We also used UAS-tkv QD (Nellen et al., 1996) , UASbabo* (Brummel et al., 1999 ) UAS-Akt1 (Staveley et al., 1998 ) and shortvein-GAL4 (shv 3KPN -GAL4; Sotillos and de Celis, 2005) . All crosses were performed on standard medium at 25°C except where indicated.
Flip-out clones
We generated SnoN overexpression clones using the flip-out technique (Ito et al., 1997) . yw, omb-lacZ, hs flp
122
; AyGAL4 UAS-eGFP/UAS-snoN males were crossed to yw, omb-lacZ, hs flp
; AyGAL4 UAS-eGFP/ AyGAL4 UAS-eGFP virgins. Heat-shock treatment (1 h at 37°C) was applied when the progeny were 24-48 h old.
Mutagenesis
Previous attempts to generate mutant snoN alleles by jump-out of EP element insertion strains were unsuccessful. Unusual chromosomal rearrangements were observed, and in one case, the snoN gene was translocated elsewhere in the genome (data not shown). As an alternative, snoN GS18054 /snoN GS18054 males were fed 0.025 M Ethyl MethaneSulfonate (EMS; Sigma) and mated with MS1096-GAL4 females (Capdevila and Guerrero, 1994) . Normally, MS1096-GAL4; snoN GS18054 /+ flies have small upturned wings. In the F1 progeny, flies showing partially or completely straightened wings were isolated. These flies were mosaic and therefore candidate lines were further tested with other GAL4 drivers to confirm the complete loss of GS-induced phenotypes. One complete revertant was isolated out of 7839 flies screened. The genomic DNA of the homozygous mutant and snoN GS18054 homozygous control flies was purified and the snoN region was amplified by PCR using high-fidelity Expand Polymerase (Roche). PCR products from two separate reactions were subsequently cloned in pGEM-T Easy (Promega) and multiple independent clones were sequenced.
UAS-snoN construct
No cDNA for snoN is publicly available, but because the genomic snoN sequence contains no predicted introns and the predicted SnoN product shares homology with mammalian Sno proteins essentially throughout its length, homozygous snoN EP(2)2510 genomic DNA was used to amplify the annotated snoN open reading frame and flanking sequences for cloning into pUAST (Brand and Perrimon, 1993) 
In situ hybridization and immunostaining
In situ hybridization was performed as described (Wolff, 2000) using a full-length snoN RNA probe. Hybridization and wash steps were performed at 65°C. For in situ and immunostaining of pupal discs, 24-28 h APF (After Puparium Formation) pupae were removed from pupal cases in 1· PBS and fixed in 4% paraformaldehyde (2 · 20 min). The pupal wings were then dissected in PBS/Triton X-100 (0.3%) before proceeding with standard protocols. The in situ protocol for pupal wings included a Proteinase K treatment (Ralston and Blair, 2005) . The primary antibodies used were: mouse anti-b-galactosidase (Promega; 1:100), rabbit anti-b-galactosidase (ICN Biomedicals; 1:5000), mouse anti-Dl (C594.9B; Qi et al., 1999 ; Developmental Studies Hybridoma Bank; 1:500), and rabbit anti-phosphorylated Mad (PS1; Persson et al., 1998; 1:2000) . Cy-labelled secondary antibodies (Jackson Immunoresearch) were used at 1:500.
Microscopy and image analysis
Eye and wing size measurements were performed as described previously (Goberdhan et al., 2005) . Pictures of eyes and wings were captured from a Leica stereomicroscope at constant magnification with a Zeiss Axiocam camera. The size of the eyes was evaluated by measuring the area of 3 · 3 ommatidia in the centre of each eye, using the Axiovision image analysis software (Zeiss). For whole wing or posterior vs anterior wing area measurements, the same software was used to outline the wing or different compartments. On average, 10 eyes or wings of each genotype were imaged and analyzed. The Student's t-test or the v 2 test of independence was performed where appropriate. Fluorescent images were captured on a Zeiss Axioplan 2 confocal microscope with a LSM 510 laser module.
